1. Efficacy of iGlarLixi, a fixed‐ratio combination of insulin glargine and lixisenatide, in patients with type 2 diabetes stratified as at high or low risk according to HEDIS measurements. Issue 11 (24th July 2018) Authors: Sugimoto, Danny H.; Dex, Terry; Stager, William; Aroda, Vanita R. Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 11(2018) Page Start: 2680 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fixed‐ratio combination of insulin glargine plus lixisenatide (iGlarLixi) improves ß‐cell function in people with type 2 diabetes. Issue 6 (28th March 2022) Authors: Ferrannini, Ele; Niemoeller, Elisabeth; Dex, Terry; Servera, Soraly; Mari, Andrea Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 6(2022) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real‐world study. Issue 5 (28th February 2023) Authors: Lajara, Rosemarie; Heller, Caroline; Pantalone, Kevin M.; Lew, Elisheva; Li, Xuan; Dex, Terry; Kilpatrick, Catherine Rachel Journal: Diabetes, obesity & metabolism Issue: Volume 25:Issue 5(2023) Page Start: 1249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of disease duration and β‐cell reserve on the efficacy of switching to iGlarLixi in adults with type 2 diabetes on glucagon‐like peptide‐1 receptor agonist therapy: Exploratory analyses from the LixiLan‐G trial. Issue 9 (28th May 2020) Authors: Del Prato, Stefano; Frias, Juan Pablo; Blonde, Lawrence; Aroda, Vanita R.; Shehadeh, Niam; Saremi, Aramesh; Dex, Terry; Niemoeller, Elisabeth; Souhami, Elisabeth; Liu, Minzhi; Rosenstock, Julio Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 9(2020) Page Start: 1567 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of lixisenatide dose range on clinical outcomes with fixed-ratio combination iGlarLixi in patients with type 2 diabetes. (3rd April 2019) Authors: Pablo Frias, Juan; Lorenz, Martin; Roberts, Michelle; Dex, Terry; Schmider, Wolfgang; Hurst, William; Skolnik, Neil Journal: Current medical research and opinion Issue: Volume 35:Number 4(2019) Page Start: 689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Improving Type 2 Diabetes Patient Health Outcomes with Individualized Continuing Medical Education for Primary Care. Issue 3 (September 2016) Authors: Lee, Brian; Trence, Dace; Inzucchi, Silvio; Lin, Jay; Haimowitz, Steven; Wilkerson, Elizabeth; Williams, Cara; Mosier, Marc; Dex, Terry Journal: Diabetes therapy Issue: Volume 7:Issue 3(2016) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Low incidence of gastrointestinal adverse events over time with a fixed‐ratio combination of insulin glargine and lixisenatide versus lixisenatide alone. Issue 11 (21st August 2018) Authors: Trujillo, Jennifer M.; Roberts, Michelle; Dex, Terry; Chao, Jason; White, John; LaSalle, James Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 11(2018) Page Start: 2690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Post hoc efficacy and safety analysis of insulin glargine/lixisenatide fixed- ratio combination in North American patients compared with the rest of world. Issue 1 (21st March 2019) Authors: Dailey, George; Bajaj, Harpreet S; Dex, Terry; Groleau, Melanie; Stager, William; Vinik, Aaron Journal: BMJ open diabetes research and care Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Predictors of outcomes in patients with type 2 diabetes in the lixisenatide GetGoal clinical trials. Issue 2 (29th November 2016) Authors: Blonde, Lawrence; Chava, Pavan; Dex, Terry; Lin, Jay; Nikonova, Elena V.; Goldenberg, Ronald M. Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 2(2017) Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. When basal insulin is not enough: A dose–response relationship between insulin glargine 100 units/mL and glycaemic control. Issue 6 (25th March 2019) Authors: Umpierrez, Guillermo E.; Skolnik, Neil; Dex, Terry; Traylor, Louise; Chao, Jason; Shaefer, Charles Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 6(2019) Page Start: 1305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗